Results 231 to 240 of about 54,453 (265)
Some of the next articles are maybe not open access.
Human medicines European public assessment report (EPAR): Remicade, infliximab, Spondylitis, Ankylosing,Arthritis, Rheumatoid,Psoriasis,Crohn Disease,Arthritis, Psoriatic,Colitis, Ulcerative, Date of authorisation: 13/08/1999, Revision: 53, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Remsima, infliximab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Colitis, Ulcerative,Psoriasis,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 10/09/2013, Revision: 15, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Inflectra, infliximab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Colitis, Ulcerative,Psoriasis,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 09/09/2013, Revision: 20, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Amgevita, adalimumab, Arthritis, Psoriatic,Colitis, Ulcerative,Arthritis, Juvenile Rheumatoid,Spondylitis, Ankylosing,Psoriasis,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 21/03/2017, Revision: 6, Status: Authorised
Case Medical Research, 2019 openaire +2 more sourcesHuman medicines European public assessment report (EPAR): Remicade, infliximab, Spondylitis, Ankylosing,Arthritis, Rheumatoid,Psoriasis,Crohn Disease,Arthritis, Psoriatic,Colitis, Ulcerative, Date of authorisation: 13/08/1999, Revision: 54, Status: Authorised
Case Medical Research, 2019 openaire +1 more source